Daniel Chan - Clarksville MD, US Zhen Zhang - Dayton MD, US Jinong Li - Ellicott City MD, US
Assignee:
Johns Hopkins University - Baltimore MD
International Classification:
C12Q001/68 G01N033/574
US Classification:
435006000, 435007230
Abstract:
The present invention relates to a method for identification of tmor biomarkers markers for breast cancer, with high specificity and sensitivity. Preferred methods of the invention include qualifying breast cancer status in a subject comprising: (a) measuring at least one of the disclosed biomarkers in a sample from the subject; and (b) correlating the measurement with breast cancer status. The invention further relates to kits for qualifying breast cancer status in a subject.
Identification Of Biomarkers For Detecting Prostate Cancer
Daniel Chan - Clarksville MD, US Jinong Li - Ellicott City MD, US Zhen Zhang - Dayton MD, US
International Classification:
C12Q001/68 G01N033/574 G01N033/00
US Classification:
435006000, 435007230, 436086000
Abstract:
The present invention relates to a method of qualifying prostate cancer status in a subject comprising: (a) measuring at least one of the disclosed biomarkers in a sample from the subject and (b) correlating the measurement with prostate cancer status. The invention further relates to kits for qualifying prostate cancer status in a subject.
Jinong Li - Ellicott City MD, US Carolyn N. White - Baltimore MD, US Zhen Zhang - Dayton MD, US Daniel W. Chan - Clarksville MD, US Eric T. Fung - Los Altos CA, US Xiao-Ying Meng - Fremont CA, US
Assignee:
The Johns Hopkins University - Baltimore MD Ciphergen Biosystems, Inc. - Fremont CA
International Classification:
G01N 33/566 G01N 33/00
US Classification:
436501, 436 64
Abstract:
The present invention provides protein-based biomarkers and biomarker combinations that are useful in qualifying breast cancer status in a patient. In particular, the biomarkers of this invention are useful to classify a subject sample as breast cancer or non-breast cancer. The biomarkers can be detected by SELDI mass spectrometry.
The present invention provides protein-based biomarkers and biomarker combinations that are useful in qualifying breast cancer status in a patient. In particular, the biomarkers of this invention are useful to classify a subject sample as breast cancer or non-breast cancer. The biomarkers can be detected by SELDI mass spectrometry.
Identification Of Biomarkers For Detecting Prostate Cancer
- Baltimore MD, US Jinong Li - Ellicott City MD, US Zhen Zhang - Dayton MD, US
Assignee:
The Johns Hopkins University - Baltimore MD
International Classification:
G01N 33/68
US Classification:
506 12, 530350, 506 18
Abstract:
The present invention relates to a method of qualifying prostate cancer status in a subject comprising: (a) measuring at least one of the disclosed biomarkers in a sample from the subject and (b) correlating the measurement with prostate cancer status. The invention further relates to kits for qualifying prostate cancer status in a subject.